HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

25-hydroxyprotopanaxatriol

anti-cancer ginsenoside; structure in first source

Also Known As:

25-OH-PPT

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Terpenes: 1461
    - Triterpenes: 2493
      - Ginsenosides: 1010
        25-hydroxyprotopanaxatriol: 2
Carbohydrates: 22023
- Glycosides: 2119
  - Saponins: 2867
    - Ginsenosides: 1010
      - 25-hydroxyprotopanaxatriol: 2

Experts

1.	Wang, Wei: 2 articles (01/2021 - 06/2008)
2.	Zhao, Yuqing: 2 articles (01/2021 - 06/2008)
3.	Bi, Xiuli: 1 article (01/2021)
4.	Ding, Meng: 1 article (01/2021)
5.	Liu, Hairong: 1 article (01/2021)
6.	Lu, Jincai: 1 article (01/2021)
7.	Su, Guangyue: 1 article (01/2021)
8.	Xu, Jing: 1 article (01/2021)
9.	Hao, Miao: 1 article (06/2008)
10.	Hill, Donald L: 1 article (06/2008)

Related Diseases

1.	Prostatic Neoplasms (Prostate Cancer) 06/01/2008 - "25-OH-PPD, but not 25-OH-PPT, inhibited prostate cancer cell growth and proliferation, induced apoptosis, and led to arrest in the G1 phase of the cell cycle. "
2.	Neoplasms (Cancer) 06/01/2008 - "We recently isolated 25-hydroxyprotopanaxadiol (25-OH-PPD) and 25-hydroxyprotopanaxatriol (25-OH-PPT) from Panax ginseng and evaluated their anti-cancer activity in vitro. "
3.	Type 2 Diabetes Mellitus (MODY) 01/01/2021 - "Meanwhile, the hypoglycemic effect and mechanism of 25-OH-PPT were evaluated by using STZ to establish insulin-dependent diabetic mice and the spontaneous type 2 diabetes DB/DB mice. "

Related Drugs and Biologics

1.	Insulin (Novolin)
2.	Hypoglycemic Agents (Hypoglycemics)
3.	25-hydroxyprotopanaxadiol